BECKER CAPITAL MANAGEMENT INC Q4 2025 Filing

Filed February 13, 2026

Portfolio Value

$3.5T

Holdings

301

Report Date

Q4 2025

Filing Type

13F-HR

All Holdings (301 positions)

StockValue
—REVIVA PHARMACEUTCLS HLDGS I
$9.0M
PreviousPage 4 of 4